Skip to main content
. Author manuscript; available in PMC: 2018 Oct 30.
Published in final edited form as: Blood. 2017 Sep 29;130(23):2504–2515. doi: 10.1182/blood-2017-03-771576

Figure 5. MCL-1 is required for mature TEC survival.

Figure 5

(A) Multi dimension scaling (MDS) plot comparing RNA-seq expression profiles for cTECs and mTECs from one month old controls and Mcl1ΔFoxn1 mice. Libraries are labelled and coloured according to the genotype and TEC subset. Distances on the plot correspond to leading log2-fold-change between each pair of samples. (B) Genes that were differentially expressed (FDR<0.05) in Mcl1ΔFoxn1 cTEC relative to controls that are involved in TEC (black) or thymocyte (grey) development. (C-F) Histograms of β5t (C), CD40 (D) expression in CD45-EpCAM+MHCII+Ly51+ cTECs and MHCI (E), CD80 (F) in CD45-EpCAM+MHCII+ TECs isolated from 5 weeks old mice (blue and red histograms show controls and Mcl1ΔFoxn1 mice, respectively). (G) Thymic cellularity (left) and TEC (CD45-MHCII+EpCAM+) numbers (right) of 4-7 week-old mice of the indicated genotypes. (H) Histogram of flow cytometric analysis of MCL-1 expression in CD45-EpCAM+MHCII+ TECs isolated from 4-7 week-old mice of the indicated genotypes. Data are representative of three independent experiments (n≥ 2/group) (except A-F). Graph bars indicate mean ± SEM and groups were compared with a Student’s t test (two sided, unpaired). ** p<0.01; *** p<0.001; **** p<0.0001.